Description Who We Are BioMarin is a global biotechnology company that relentlessly pursues bold science... advances to patients who live with genetic diseases. SUMMARY: The BioMarin Summer Internship Program will enable students...
Description Who We Are BioMarin is a global biotechnology company that relentlessly pursues bold science... advances to patients who live with genetic diseases. SUMMARY: The BioMarin Summer Internship Program will enable students...
Description Who We Are BioMarin is a global biotechnology company that relentlessly pursues bold science... or offer a substantial benefit over existing therapeutic options. About Corporate Groups It takes a village, and at BioMarin...
Description Who We Are BioMarin is a global biotechnology company that relentlessly pursues bold science..., protocols, study reports and regulatory documents Collaborate with various BioMarin functions, CROs, university or analytical...
Description Who We Are BioMarin is a global biotechnology company that relentlessly pursues bold science... for providing administrative support to VP Level leaders at BioMarin. This person will also support some of the respective function...
We Are / Background BioMarin is a global biotechnology company that relentlessly pursues bold science to translate genetic discoveries... initiatives with functions in BioMarin and throughout TOPS. This role offers a unique opportunity to shape the future of BioMarin...
Description Who We Are BioMarin is a global biotechnology company that relentlessly pursues bold science...
Description Who We Are BioMarin is a global biotechnology company that relentlessly pursues bold science...
Description About Technical Operations BioMarin's Technical Operations group is responsible for creating our drugs..., scientists and support staff build and maintain BioMarin's cutting-edge manufacturing processes and sites, provide quality...
Description BioMarin is the world leader in delivering therapeutics that provide meaningful advances to patients who..., progressively debilitating and have few, if any, treatment options. BioMarin will continue to focus on advancing therapies...